False-negative prenatal diagnosis of restrictive dermopathy
✍ Scribed by Hamel, B. C. J. ;Happle, R. ;Steylen, P. M. ;Kollée, L. A. A. ;Stekhoven, J. H. Schuurmans ;Nijhuis, J. G. ;Rauskolb, R. ;Anton-Lamprecht, I.
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 298 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0148-7299
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Glycogen storage disease type Ia (GSD Ia) is an autosomal recessive condition, caused by a deficiency of hepatic glucose-6-phosphatase (G6Pase) activity. In a consanguineous family originating from northern Africa whose first daughter was affected with GSD Ia, we were able to identify the disease-ca
Maternal age-speci®c rates of Down syndrome used in serum screening
Prenatal diagnosis of fragile X syndrome requires detection of the full FMR1 mutation in chorionic villus or amniotic fluid cell samples. Although analysis of genomic DNA restriction fragment pattern is a highly reliable technique for identification of the full FMR1 mutation, standard Southern blot
## Background: As fine-needle aspiration (fna) has become a critical component of the investigation of palpable breast masses, false-negative diagnoses have become a major concern, prompting reevaluation of the definition of specimen adequacy. although cytopathologists agree that a number of parame